-

 

INSOMNIA SUFFERERS: CBT HELPFUL




Struggling with insomnia isn’t just about losing sleep at night—it often means dragging through the day, feeling worn out, and facing a higher risk of health problems. It’s a vicious cycle, and one that often goes hand-in-hand with depression, anxiety, and stress. But there’s good news: breaking free is possible.

A recent study of more than 450 Australians battling insomnia brought some hope. Researchers at Flinders University found that targeted cognitive behavioral therapy for insomnia (CBTi) doesn’t just help people sleep better—it also eases symptoms of depression, anxiety, and stress. Lead researcher Dr. Alexander Sweetman notes that, especially in a world full of stressors like COVID-19, treating insomnia can spark dramatic improvements in overall well-being and mental health.

The study followed 455 people through a CBTi program, tracking their progress from the first session to three months after treatment. The results? Sleep improved for everyone, whether or not they started with depression, anxiety, or stress—and those mental health symptoms got noticeably better, too.

Professor Leon Lack, who oversees the insomnia clinic at Flinders, says CBTi remains the gold standard for tackling insomnia. The university now offers both in-person and telehealth treatments for people across Australia, making expert help more accessible than ever. They’re also developing programs for general practitioners, aiming to help more people find real sleep solutions without relying heavily on medication.

If you’re struggling with sleep, don’t wait for things to get worse. Simple lifestyle changes—like sticking to a consistent bedtime, limiting screen time before bed, and getting regular exercise—can make a real difference. And if you need extra support, ProTime-Fitness at ProTime-Fitness.org offers resources and guidance to help you build healthier habits and finally get the rest you deserve.

Comments

Post a Comment

Popular posts from this blog

B12 MAY HELP PREVENT ALZHEIMER'S DISEASE.

-
Image
  B12 MAY HELP PREVENT ALZHEIMER'S DISEASE. Worms don't wiggle when they have Alzheimer's disease. Yet something helped worms with the disease hold onto their wiggle in Professor Jessica Tanis's lab at the University of Delaware. In solving the mystery, Tanis and her team have yielded new clues into the potential impact of diet on Alzheimer's, the dreaded degenerative brain disease afflicting more than 6 million Americans. A few years ago, Tanis and her team began investigating factors affecting the onset and progression of Alzheimer's disease. They were doing genetic research with  C. elegans , a tiny soil-dwelling worm subject of numerous studies. Expression of amyloid-beta, a toxic protein implicated in Alzheimer's disease, paralyzes worms within 36 hours of reaching adulthood. While the worms in one petri dish in Tanis's lab were rendered completely immobile, the worms of the same age in the adjacent petri dish still had their wiggle, documented as ...
Read more

EXTREME HEAT MAY NEGATIVELY IMPACT COGNITIVE HEALTH

-
Image
  EXTREME HEAT MAY NEGATIVELY IMPACT COGNITIVE HEALTH          July 2023 was the hottest month, with cities like Phoenix experiencing record-breaking heat waves for weeks. A new study finds that ongoing extreme heat can worsen cognitive decline among vulnerable groups -- particularly Black older adults and those living in poor neighborhoods. "Our research finds that cumulative exposure to extreme heat can undermine cognitive health, but it does so unequally across the population," said Eunyoung Choi, a postdoctoral associate at the NYU School of Global Public Health and the first author of the study, published in the  Journal of Epidemiology and Community Health . Extreme heat is the leading cause of weather-related deaths in the U.S., claiming more lives each year than hurricanes, tornadoes, and lightning combined. Young children and older adults are particularly vulnerable to heat-related illnesses such as heat exhaustion and heat stroke. Recent stud...
Read more

Diabetes drugs may reduce the risk of Alzheimer’s.

-
Image
    Diabetes drugs may reduce the risk of Alzheimer’s. The study finds people taking the drugs have fewer biomarkers, slower cognitive decline. People taking certain drugs to lower blood sugar for type 2 diabetes had less amyloid in the brain, a biomarker of Alzheimer's disease compared to people with type 2 diabetes who are not taking the drugs and those without diabetes. The new study, published in the August 11, 2021, online issue of  Neurology , the medical journal of the American Academy of Neurology, also found people taking these drugs, called dipeptidyl peptidase-4 inhibitors, showed slower cognitive decline than people in the other two groups. In people with type 2 diabetes, the body no longer efficiently uses insulin to control blood sugar. Dipeptidyl peptidase-4 inhibitors, also known as gliptins, can be prescribed when other diabetes drugs do not work. They help control blood sugar when combined with diet and exercise. "People with diabetes have been shown to ...
Read more